The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Cancer statistics, 2018
Open accessAbstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the National Center for Health Statistics. In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2005‐2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006‐2015) declined by about 1.5% annually in both men and women. The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Of the 10 leading causes of death, only cancer declined from 2014 to 2015. In 2015, the cancer death rate was 14% higher in non‐Hispanic blacks (NHBs) than non‐Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13‐1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29‐1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06‐1.09) and varied substantially by state. For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16‐3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56‐2.02), Kansas (DRR, 1.51; 95% CI, 1.25‐1.81), Louisiana (DRR, 1.49; 95% CI, 1.38‐1.60), Illinois (DRR, 1.48; 95% CI, 1.39‐1.57), and California (DRR, 1.45; 95% CI, 1.38‐1.54). Larger racial inequalities in young and middle‐aged adults probably partly reflect less access to high‐quality health care. CA Cancer J Clin 2018;68:7‐30 . © 2018 American Cancer Society .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Self-citationScreening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
National Conference of State Legislatures
(2011) · Reference Reviews · doi:10.1108/09504121111114072 · Cited by 2,315
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002
Self-citationBreast cancer statistics, 2017, racial disparity in mortality by state
DeSantis, C. E., Ma, J., Goding Sauer, A., Newman, L. A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21412 · Cited by 1,879
Self-citationCancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,801
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Self-citation
Cited by
Items 301–367 of 367
Application of liquid biopsy in bone and soft tissue sarcomas: Present and future
Li, X., Seebacher, N. A., Hornicek, F. J., Xiao, T., & Duan, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.012 · Cited by 53
Gonzalez-Villasana, V., Rashed, M. H., Gonzalez-Cantú, Y., Bayraktar, R., Menchaca-Arredondo, J. L., Vazquez-Guillen, J. M., Rodriguez-Padilla, C., Lopez-Berestein, G., & Resendez-Perez, D. (2019) · Disease Markers · doi:10.1155/2019/6852917 · Cited by 53
Interethnic differences in pancreatic cancer incidence and risk factors: The Multiethnic Cohort
Huang, B. Z., Stram, D. O., Le Marchand, L., Haiman, C. A., Wilkens, L. R., Pandol, S. J., Zhang, Z., Monroe, K. R., & Setiawan, V. W. (2019) · Cancer Medicine · doi:10.1002/cam4.2209 · Cited by 52
An omentum-inspired 3d peg hydrogel for identifying ecm-drivers of drug resistant ovarian cancer
Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5091713 · Cited by 51
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
Psychosocial interventions for informal caregivers of lung cancer patients: a systematic review
Kedia, S. K., Collins, A., Dillon, P. J., Akkus, C., Ward, K. D., & Jackson, B. M. (2020) · Psycho-Oncology · doi:10.1002/pon.5271 · Cited by 51
Systems Biology, Systems Medicine, Systems Pharmacology: The What and The Why
Stéphanou, A., Fanchon, E., Innominato, P. F., & Ballesta, A. (2018) · Acta Biotheoretica · doi:10.1007/s10441-018-9330-2 · Cited by 50
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer
Cohen, A. S., Geng, L., Zhao, P., Fu, A., Schulte, M. L., Graves-Deal, R., Washington, M. K., Berlin, J., Coffey, R. J., & Manning, H. C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100828 · Cited by 49
Li, H., Chen, J., Li, Z., Chen, M., Ou, Z., Mo, M., Wang, R., Tong, S., Liu, P., Cai, Z., et al. (2023) · Advanced Science · doi:10.1002/advs.202300110 · Cited by 49
Jabalera, Y., Garcia-Pinel, B., Ortiz, R., Iglesias, G., Cabeza, L., Prados, J., Jimenez-Lopez, C., & Melguizo, C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080395 · Cited by 49
Liao, L., Ge, M., Zhan, Q., Huang, R., Ji, X., Liang, X., & Zhou, X. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29203 · Cited by 48
Almeida, P. P., Cardoso, C. P., & de Freitas, L. M. (2020) · BMC Cancer · doi:10.1186/s12885-020-6533-0 · Cited by 48
Zhang, H., Yin, X., Zhang, X., Zhou, M., Xu, W., Wei, Z., Song, C., Han, S., & Han, W. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221118202 · Cited by 40
Current status of surgical treatment of colorectal liver metastases
Xu, F., Tang, B., Jin, T.-Q., & Dai, C.-L. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i14.716 · Cited by 45
Reis, J. C., Antoni, M. H., & Travado, L. (2020) · CNS Spectrums · doi:10.1017/s1092852918001621 · Cited by 44
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
Bittoni, A., Pecci, F., Mentrasti, G., Crocetti, S., Lupi, A., Lanese, A., Pellei, C., Ciotti, C., Cantini, L., Giampieri, R., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-3499 · Cited by 42
Zhu, X., Tian, X., Ji, L., Zhang, X., Cao, Y., Shen, C., Hu, Y., Wong, J. W. H., Fang, J.-Y., Hong, J., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00142-x · Cited by 41
Hoang, L. T., Domingo‐Sabugo, C., Starren, E. S., Willis‐Owen, S. A. G., Morris‐Rosendahl, D. J., Nicholson, A. G., Cookson, W. O. C. M., & Moffatt, M. F. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12568 · Cited by 39
Schultz, C. W., McCarthy, G. A., Nerwal, T., Nevler, A., DuHadaway, J. B., McCoy, M. D., Jiang, W., Brown, S. Z., Goetz, A., Jain, A., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0652 · Cited by 34
Engineering cell heterogeneity into organs-on-a-chip
Mertz, D. R., Ahmed, T., & Takayama, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00413g · Cited by 33
Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS -driven tumors
Jiang, H., Muir, R. K., Gonciarz, R. L., Olshen, A. B., Yeh, I., Hann, B. C., Zhao, N., Wang, Y.-H., Behr, S. C., Korkola, J. E., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20210739 · Cited by 33
Deng, Y., Ming, B., Zhou, T., Wu, J.-L., Chen, Y., Liu, P., Zhang, J., Zhang, S.-Y., Chen, T.-W., & Zhang, X.-M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.620981 · Cited by 32
Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
Zhang, X., Schönrogge, M., Eichberg, J., Wendt, E. H. U., Kumstel, S., Stenzel, J., Lindner, T., Jaster, R., Krause, B. J., Vollmar, B., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00590 · Cited by 31
Zhao, P., Wu, Z., Li, C., Yang, G., Ding, J., Wang, K., Wang, M., Feng, L., Duan, G., & Li, H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233412 · Cited by 31
Du, Z., Weinhold, N., Song, G. C., Rand, K. A., Van Den Berg, D. J., Hwang, A. E., Sheng, X., Hom, V., Ailawadhi, S., Nooka, A. K., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000491 · Cited by 31
Li, Q., Sun, Y., Zhang, X., Wang, L., Wu, W., Wu, M., Meng, C., & Liu, G. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1595278 · Cited by 30
Miao, S., Qiu, T., Zhao, Y., Wang, H., Sun, X., Wang, Y., Xuan, Y., Qin, Y., & Jiao, W. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12797 · Cited by 28
Chen, Y.-Q., Kuo, J.-C., Wei, M.-T., Chen, Y.-C., Yang, M.-H., & Chiou, A. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.11.046 · Cited by 29
Jacobs, S. A., Lee, J. J., George, T. J., Wade, J. L., Stella, P. J., Wang, D., Sama, A. R., Piette, F., Pogue-Geile, K. L., Kim, R. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1831 · Cited by 27
Lin, A., Zhang, H., Meng, H., Deng, Z., Gu, T., Luo, P., & Zhang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667875 · Cited by 27
Patients' perspective on digital technologies in advanced genitourinary cancers
Rodler, S., Buchner, A., Stief, C. G., Heinemann, V., Staehler, M., & Casuscelli, J. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2020.03.018 · Cited by 27
Covrig, V. I., Lazăr, D. E., Costan, V. V., Postolică, R., & Ioan, B. G. (2021) · Medicina · doi:10.3390/medicina57101078 · Cited by 28
Fusobacterium nucleatum carcinogenesis and drug delivery interventions
Chen, Z., & Huang, L. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115319 · Cited by 27
Jabalera, Y., Sola-Leyva, A., Peigneux, A., Vurro, F., Iglesias, G. R., Vilchez-Garcia, J., Pérez-Prieto, I., Aguilar-Troyano, F. J., López-Cara, L. C., Carrasco-Jiménez, M. P., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080408 · Cited by 27
Sadigh, S., Farahani, S. J., Shah, A., Vaughn, D., & Lal, P. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz184 · Cited by 26
Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
Jewell, A., McMahon, M., & Khabele, D. (2018) · Cancers · doi:10.3390/cancers10090296 · Cited by 24
Kim, N. Y., Jung, Y. Y., Yang, M. H., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., & Ahn, K. S. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.018 · Cited by 24
Zhang, X., Wang, J., Lu, J., Su, L., Wang, C., Huang, Y., Zhang, X., & Zhu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.689626 · Cited by 24
Zhao, K., Wang, C., Shi, F., Huang, Y., Ma, L., Li, M., & Song, Y. (2021) · BMC Cancer · doi:10.1186/s12885-021-07784-x · Cited by 21
The role of miR-106p-5p in cervical cancer: from expression to molecular mechanism
Yi, Y., Liu, Y., Wu, W., Wu, K., & Zhang, W. (2018) · Cell Death Discovery · doi:10.1038/s41420-018-0096-8 · Cited by 23
Joshi, V. B., Behl, S., Pittock, S. T., Arndt, C. A. S., Zhao, Y., Khan, Z., Granberg, C. F., & Chattha, A. (2021) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2021.04.006 · Cited by 23
Lu, X., Lin, B., Xu, N., Huang, H., Wang, Y., & Lin, J.-M. (2020) · Talanta · doi:10.1016/j.talanta.2020.120732 · Cited by 23
Kanno, Y., Koshita, S., Ogawa, T., Kusunose, H., Masu, K., Sakai, T., Yonamine, K., Kawakami, Y., Fujii, Y., Miyamoto, K., et al. (2019) · Clinical Endoscopy · doi:10.5946/ce.2019.018 · Cited by 23
Zhang, W., Zhang, K., Ma, Y., Song, Y., Qi, T., Xiong, G., Zhang, Y., Kan, C., Zhang, J., Han, F., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115344 · Cited by 22
Long, L., Zhang, X., Bai, J., Li, Y., Wang, X., & Zhou, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s198966 · Cited by 21
miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells
Tang, H., Lv, W., Sun, W., Bi, Q., & Hao, Y. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4041 · Cited by 21
Artificial Intelligence-assisted colonoscopy and colorectal cancer screening: Where are we going?
Spadaccini, M., Troya, J., Khalaf, K., Facciorusso, A., Maselli, R., Hann, A., & Repici, A. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.01.203 · Cited by 20
Xu, J.-Z., Wang, W.-Q., Zhang, W.-H., Xu, H.-X., Gao, H.-L., Zhang, S.-R., Wu, C.-T., Li, S., Li, H., Xu, J., et al. (2019) · Journal of Cancer · doi:10.7150/jca.30883 · Cited by 19
Mitchell, J., Camacho, N., Shea, P., Stopsack, K. H., Joseph, V., Burren, O. S., Dhindsa, R. S., Nag, A., Berchuck, J. E., O’Neill, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56944-1 · Cited by 19
Liu, L., Zhang, J., Deapen, D., Stern, M. C., Sipin, A., Pandol, S. J., & Setiawan, V. W. (2019) · Pancreas · doi:10.1097/mpa.0000000000001337 · Cited by 18
Current First-line Therapy for Ovarian Cancer: A Comprehensive Review
Pierce, S. R., & Clark, L. H. (2018) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000613 · Cited by 17
Wang, L., Kumar, M., Deng, Q., Wang, X., Liu, M., Gong, Z., Zhang, S., Ma, X., Xu-Monette, Z. Y., Xiao, M., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2018.10.009 · Cited by 16
Werneth, C. M., Slaba, T. C., Huff, J. L., Patel, Z. S., & Simonsen, L. C. (2022) · Health Physics · doi:10.1097/hp.0000000000001572 · Cited by 13
Miyata, K., Zhou, X., Nishio, M., Hanyu, A., Chiba, M., Kawasaki, H., Osako, T., Takeuchi, K., Ohno, S., Ueno, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305046120 · Cited by 14
Kurita, A., Mori, Y., Someya, Y., Kubo, S., Azuma, S., Iwano, K., Ikeda, S., Okumura, R., & Yazumi, S. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03199-1 · Cited by 13
Jansen, B. H. E., Jansen, R. W., Wondergem, M., Srbljin, S., de Klerk, J. M. H., Lissenberg-Witte, B. I., Vis, A. N., van Moorselaar, R. J. A., Boellaard, R., Hoekstra, O. S., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.222513 · Cited by 12
Charalel, R. A., Mushlin, A. I., Li, D., Mao, J., Ibrahim, S., Carlos, R. C., Kwan, S. W., Fortune, B., Talenfeld, A. D., Brown, R. S., et al. (2022) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2022.07.010 · Cited by 11
Neal, A. S., Nunez, M., Lai, T., Tosevska, A., Morselli, M., Amneus, M., Zakhour, M., Moatamed, N. A., Pellegrini, M., & Memarzadeh, S. (2020) · Reproductive Sciences · doi:10.1007/s43032-020-00175-w · Cited by 11
Banbury, S., Chandler, C., & Lusher, J. (2023) · Psych · doi:10.3390/psych5010015 · Cited by 11
Khatri, W., Chung, H. W., Werner, R. A., Leal, J. P., Pienta, K. J., Lodge, M. A., Gorin, M. A., Pomper, M. G., & Rowe, S. P. (2021) · Diagnostics · doi:10.3390/diagnostics11040665 · Cited by 10
CAPER as a therapeutic target for triple negative breast cancer
Campbell, M. C., Pontiggia, L., Russell, A. Y., Schwarting, R., Camacho, J., Jasmin, J.-F., & Mercier, I. (2018) · Oncotarget · doi:10.18632/oncotarget.25719 · Cited by 10
Maas, A., Maurice‐Stam, H., Feijen, E. A. M. (., Teepen, J. C., van der Aa‐van Delden, A. M., Streefkerk, N., van Dulmen‐den Broeder, E., Tissing, W. J. E., Loonen, J. J., van der Pal, H. J. H., et al. (2024) · Psycho-Oncology · doi:10.1002/pon.9313 · Cited by 8
Mills, M., Liveringhouse, C., Lee, F., Nanda, R. H., Ahmed, K. A., Washington, I. R., Thapa, R., Fridley, B. L., Blumencranz, P., Extermann, M., et al. (2021) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2020.08.007 · Cited by 7
Targeted Cancer Stem Cell Therapeutics: An Update
Fatima, N., Umar, M., Ambreen, S., Shaququzzaman, M., Alam, M. M., & Ali, R. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266275014240110071351 · Cited by 6
Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases
Zhao, S., Wang, R., Song, S., Hao, D., Han, G., Song, X., Zhang, J., Pizzi, M. P., Shanbhag, N., Futreal, A., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106913 · Cited by 5
Wang, T., Zhang, D., Guo, C., & Zhu, W. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220221115007 · Cited by 4
Prognostic value of SMAD4 in resectable pancreatic cancer
Su, H., & Wang, C. (2022) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2022-0036 · Cited by 1
Metadata
- Authors
- Siegel, R. L., Miller, K. D., & Jemal, A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 68
- Issue
- 1
- Pages
- 7-30
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2781525129
- Cited by
- 16,579
- References
- 65
- FWCI
- 1063.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.